Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Everolimus + Exemestane has received approval from both the FDA and EMA for the treatment of Breast cancer / Mammacarcinoma (HR+ Her2-) in postmenopausal women. This approval is specifically for cases where there has been a failure or progression following treatment with a non-steroidal aromatase inhibitor (letrozole or [anastrozole](brain://lXLTmts5jkCnbRLyT7onDA/AnastrozoleBr…